WES | Small Caps

Pointerra ASX 3DP Wesfarmers Decipher 3D geospatial data technology

Wesfarmers’ subsidiary Decipher licences Pointerra’s 3D data technology

May 27, 2019

Wesfarmers’ (ASX: WES) Decipher business will licence Pointerra’s (ASX: 3DP) 3D data technology to provide unique insights to customers across agriculture, waste and mining sectors. According to Po...

Wesfarmers Kidman Resources ASX KDR WES lithium takeover bid

Wesfarmers lines up Kidman Resources as latest takeover target

May 2, 2019

Kidman Resources (ASX: KDR) has become Wesfarmers’ (ASX: WES) latest takeover target after the conglomerate lobbed a $776 million bid for the advanced lithium explorer. Today’s bid come less than t...

Wesfarmers rare earths takeover bid Lynas Corp ASX WES LYC

Wesfarmers eyes rare earths market with $1.5b takeover bid for Lynas Corp

March 27, 2019

Wesfarmers Limited (ASX: WES) has made a surprise $1.5 billion grab for rare earths miner Lynas Corporation (ASX: LYC), offering Lynas shareholders a cash price of $2.25 per Lynas share, representing ...

Wesfarmers ASX WES Coles COL Bunnings profit dividend 2019

Wesfarmers shows it’s better off without Coles, rewards shareholders with special dividend

February 22, 2019

Wesfarmers (ASX: WES) is looking like a new and much more exciting company after it slimmed down and divested itself of Coles (ASX: COL). It is not just the special dividend of $1 a share that acco...

RECENT POSTS

Delorean Corporation ASX DEL IPO bioenergy

ASX debutant Delorean to divert waste from landfill with bioenergy projects

April 12, 2021

3D Metalforge ASX 3MF Hybrid Wire Arc printer Additive Manufacturing

3D Metalforge commissions new high performance metal printer

April 12, 2021

Medlab Clinical ASX MDC NanaBis Observational Study cannabinoid treatment cancer bone pain

Medlab’s NanaBis drug dramatically improves cancer-induced bone pain for first patient group in treatment study

April 12, 2021

Creso Pharma ASX CPH Halucenex Life Sciences LSD MDMA Ketamine psychedelic mushrooms Post Traumatic Stress Disorder PTSD mental health

Creso Pharma acquisition target Halucenex joins forces with US biotech to explore the use of magic mushrooms in treating mental illness

April 12, 2021

STOCK SUMMARY

INVESTOR TOOLS

FOLLOW US

HOT TOPICS

Bad vaccine news fails ASX shake share market recovery April 2021

Weekly review: bad vaccine news fails to shake share market recovery

April 10, 2021

Craft beer market ASX

Craft beer market offers plenty of upside to discerning operators

April 7, 2021

Loan thaw booming prices banks borrowers Australia foreclosure property

A successful loan ‘thaw’ and booming prices has taken the pressure off banks and borrowers

April 7, 2021

TRENDING POSTS

Kingsgate Consolidation ASX KCN TAFTA lawsuit closure Chatree gold mine Thailand

Kingsgate wins multi-million dollar claim over closure of its Chatree gold mine in Thailand

Craft beer market ASX

Craft beer market offers plenty of upside to discerning operators

Bad vaccine news fails ASX shake share market recovery April 2021

Weekly review: bad vaccine news fails to shake share market recovery

Delorean Corporation ASX DEL IPO bioenergy

ASX debutant Delorean to divert waste from landfill with bioenergy projects

Lithium stocks ASX

Lithium stocks on the ASX: The Ultimate Guide

FatFish FFG ASX RightBridge Ventures Abelco Esports Modelio Equity

Fatfish Group and subsidiary Abelco back RightBridge’s eSports strategy in $8.4m funding round

Montem Resources MR1 ASX hard coking coal seams drilling Chinook Vicary open pit mining

Montem Resources unearths thick coal seams in all Chinook Vicary drill holes

Fatfish lending licence license ASX FFG BNPL Southeast Asia Malaysia Forever Pay

Fatfish Group makes acquisition ahead of South East Asia BNPL rollout

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.